![]() Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research. ![]() All medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. Please consult your physician for personalized medical advice. The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional it is not intended to constitute medical advice. Mechanisms of axonal injury in experimental glaucomaĮxperimental models to study trabecular meshwork pathologyĬross-talk between glaucoma pathogenic signaling pathways in the TMīrightFocus is a tax-exempt nonprofit organization under section 501(c)(3) of the Internal Revenue Code of the United States.Ĭopyright 2000 - 2020 BrightFocus Foundation. Non-rodent models of glaucomatous optic nerve damage Inducible rodent models of glaucomatous optic nerve damage New OCT developments and application to experimental glaucomaīiomechanics of outflow dysfunction in glaucoma OCT in the diagnosis and management of glaucoma Glaucoma Therapeutics in the Pipeline and the Future John Morrison, MD, Oregon Health and Science UniversityĮpidemiology and Public Health Impact of Glaucoma ![]() Preeti Subramanian, PhD, BrightFocus Foundation Introduction of BrightFocus Glaucoma Fast Track List of topics and speakers for 2022 Glaucoma Fast Track TIME (On mobile devices, you may need to swipe left to see all of the table columns below.)
0 Comments
Leave a Reply. |